Hereditary Cancer Testing Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4168398
- 126 Pages
- January 2021
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Hereditary Cancer Testing market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Hereditary Cancer Testing market segmented into
RNA Testing
DNA Testing
Based on the end-use, the global Hereditary Cancer Testing market classified into
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other Cancers
Based on geography, the global Hereditary Cancer Testing market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Ambry Genetics (Konica Minota)
Asper Biogene
Natera
Caris Life Sciences
BioReference Laboratories (GeneDx)
LabSolutions
Progenity，Inc
ARUP Laboratories
NeoGenomics
Blueprint Genetics
CellMax Life
Fulgent Genetics
Myriad Genetics
Myogenes
LabCorp
Quest Diagnostics
Pathway Genomics
Strand Life Sciences
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL HEREDITARY CANCER TESTING INDUSTRY
2.1 Summary about Hereditary Cancer Testing Industry
2.2 Hereditary Cancer Testing Market Trends
2.2.1 Hereditary Cancer Testing Production & Consumption Trends
2.2.2 Hereditary Cancer Testing Demand Structure Trends
2.3 Hereditary Cancer Testing Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 RNA Testing
4.2.2 DNA Testing
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Breast Cancer
4.3.2 Gastrointestinal Cancer
4.3.3 Prostate Cancer
4.3.4 Respiratory/Lung Cancer
4.3.5 Other Cancers
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 RNA Testing
5.2.2 DNA Testing
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Breast Cancer
5.3.2 Gastrointestinal Cancer
5.3.3 Prostate Cancer
5.3.4 Respiratory/Lung Cancer
5.3.5 Other Cancers
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 RNA Testing
6.2.2 DNA Testing
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Breast Cancer
6.3.2 Gastrointestinal Cancer
6.3.3 Prostate Cancer
6.3.4 Respiratory/Lung Cancer
6.3.5 Other Cancers
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 RNA Testing
7.2.2 DNA Testing
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Breast Cancer
7.3.2 Gastrointestinal Cancer
7.3.3 Prostate Cancer
7.3.4 Respiratory/Lung Cancer
7.3.5 Other Cancers
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 RNA Testing
8.2.2 DNA Testing
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Breast Cancer
8.3.2 Gastrointestinal Cancer
8.3.3 Prostate Cancer
8.3.4 Respiratory/Lung Cancer
8.3.5 Other Cancers
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 RNA Testing
9.2.2 DNA Testing
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Breast Cancer
9.3.2 Gastrointestinal Cancer
9.3.3 Prostate Cancer
9.3.4 Respiratory/Lung Cancer
9.3.5 Other Cancers
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Ambry Genetics (Konica Minota)
10.1.2 Asper Biogene
10.1.3 Natera
10.1.4 Caris Life Sciences
10.1.5 BioReference Laboratories (GeneDx)
10.1.6 LabSolutions
10.1.7 Progenity，Inc
10.1.8 ARUP Laboratories
10.1.9 NeoGenomics
10.1.10 Blueprint Genetics
10.1.11 CellMax Life
10.1.12 Fulgent Genetics
10.1.13 Myriad Genetics
10.1.14 Myogenes
10.1.15 LabCorp
10.1.16 Quest Diagnostics
10.1.17 Pathway Genomics
10.1.18 Strand Life Sciences
10.2 Hereditary Cancer Testing Sales Date of Major Players (2017-2020e)
10.2.1 Ambry Genetics (Konica Minota)
10.2.2 Asper Biogene
10.2.3 Natera
10.2.4 Caris Life Sciences
10.2.5 BioReference Laboratories (GeneDx)
10.2.6 LabSolutions
10.2.7 Progenity，Inc
10.2.8 ARUP Laboratories
10.2.9 NeoGenomics
10.2.10 Blueprint Genetics
10.2.11 CellMax Life
10.2.12 Fulgent Genetics
10.2.13 Myriad Genetics
10.2.14 Myogenes
10.2.15 LabCorp
10.2.16 Quest Diagnostics
10.2.17 Pathway Genomics
10.2.18 Strand Life Sciences
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Hereditary Cancer Testing Product Type Overview
2.Table Hereditary Cancer Testing Product Type Market Share List
3.Table Hereditary Cancer Testing Product Type of Major Players
4.Table Brief Introduction of Ambry Genetics (Konica Minota)
5.Table Brief Introduction of Asper Biogene
6.Table Brief Introduction of Natera
7.Table Brief Introduction of Caris Life Sciences
8.Table Brief Introduction of BioReference Laboratories (GeneDx)
9.Table Brief Introduction of LabSolutions
10.Table Brief Introduction of Progenity，Inc
11.Table Brief Introduction of ARUP Laboratories
12.Table Brief Introduction of NeoGenomics
13.Table Brief Introduction of Blueprint Genetics
14.Table Brief Introduction of CellMax Life
15.Table Brief Introduction of Fulgent Genetics
16.Table Brief Introduction of Myriad Genetics
17.Table Brief Introduction of Myogenes
18.Table Brief Introduction of LabCorp
19.Table Brief Introduction of Quest Diagnostics
20.Table Brief Introduction of Pathway Genomics
21.Table Brief Introduction of Strand Life Sciences
22.Table Products & Services of Ambry Genetics (Konica Minota)
23.Table Products & Services of Asper Biogene
24.Table Products & Services of Natera
25.Table Products & Services of Caris Life Sciences
26.Table Products & Services of BioReference Laboratories (GeneDx)
27.Table Products & Services of LabSolutions
28.Table Products & Services of Progenity，Inc
29.Table Products & Services of ARUP Laboratories
30.Table Products & Services of NeoGenomics
31.Table Products & Services of Blueprint Genetics
32.Table Products & Services of CellMax Life
33.Table Products & Services of Fulgent Genetics
34.Table Products & Services of Myriad Genetics
35.Table Products & Services of Myogenes
36.Table Products & Services of LabCorp
37.Table Products & Services of Quest Diagnostics
38.Table Products & Services of Pathway Genomics
39.Table Products & Services of Strand Life Sciences
40.Table Market Distribution of Major Players
41.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
42.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
43.Table Global Hereditary Cancer Testing Market Forecast (Million USD) by Region 2021f-2026f
44.Table Global Hereditary Cancer Testing Market Forecast (Million USD) Share by Region 2021f-2026f
45.Table Global Hereditary Cancer Testing Market Forecast (Million USD) by Demand 2021f-2026f
46.Table Global Hereditary Cancer Testing Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
